Hypertensive patient and Medtronic clinician who focuses on hypertension (HTN) management and high blood pressure (HBP) treatments.

SPYRAL HTN GLOBAL CLINICAL TRIAL PROGRAM

ADVANCING THE SCIENCE OF RENAL DENERVATION

The SPYRAL HTN Global Clinical Trial program, including the SPYRAL HTN-ON MED and SPYRAL HTN-OFF MED trials, is a multi-phase clinical strategy designed to study the renal denervation procedure for patients with uncontrolled hypertension.

CAUTION: Investigational device. Limited by U.S. law to investigational use.

STUDY DESIGN SUMMARIES

SPYRAL HTN-OFF MED PIVOTAL TRIAL

  • Official title: Global Clinical Study of Renal Denervation With the Symplicity Spyral™ Multi-electrode Renal Denervation System in Patients With Uncontrolled Hypertension in the Absence of Antihypertensive Medications (SPYRAL PIVOTAL – SPYRAL HTN-OFF MED trial)
  • Population: Up to 433

SPYRAL HTN-ON MED IDE

  • Official title: Global Clinical Study of Renal Denervation With the Symplicity Spyral™ Multi-electrode Renal Denervation System in Patients With Uncontrolled Hypertension on Standard Medical Therapy (SPYRAL HTN-ON MED)
  • Population: Up to 340

REGISTER FOR CLINICAL TRIAL UPDATES

Register to receive information about the latest Medtronic RDN clinical trial data.

SIGN UP FOR EMAIL

EXPLORE RDN FURTHER

Get the latest news about RDN and see if there is an upcoming event near you.

VISIT NEWS AND EVENTS

Disclaimer: This page may include information about products that may not be available in your region or country. Please consult the approved indications for use. Content on specific Medtronic products is not intended for users in markets that do not have authorization for use.

CAUTION.  Investigational device. Limited by U.S. law to investigational use.